Key result
Administration of sympathetic blocking agents and 100% oxygen reduced pulmonary arteriolar resistance in patients with mitral valvular disease, correlating with sympathetic hyperactivity (r=0.62).
Why the study?
Do sympathetic blocking agents and 100% oxygen reduce pulmonary arteriolar resistance in patients with mitral valvular disease and elevated left atrial pressure?
Observational
Do sympathetic blocking agents and 100% oxygen reduce pulmonary arteriolar resistance in patients with mitral valvular disease and elevated left atrial pressure?
Sympathetic hyperactivity contributes to functional vasoconstriction and pulmonary hypertension in patients with mitral valvular disease.
May reduce pulmonary arteriolar resistance via sympathetic blockade in mitral valve disease; hypothesis-generating and should not yet change practice.
The relations of pulmonary hemodynamics and the urinary catecholamine were investigated in patients with elevated left atrial pressure, and also the effects of 100 per cent oxygen and sympathetic blocking agents, such as phentolamine and hexamethonium, on pulmonary circulation were studied. Noradrenaline and the ratio of noradrenaline to adrenaline were higher in mitral valvular disease compared with control subjects, and somewhat better correlation (r=0.62) was obtained between the ratio of noradrenaline to adrenaline and the pulmonary arteriolar resistance. Administration of sympathetic blocking agents and inhalation of 100 per cent oxygen were followed by the reduction in pulmonary arteriolar resistance, and the decrement was found to be remarkable in those with the higher control values. From these evidences it is concluded that the functional vasoconstriction due to the sympathetic hyperactivity can make an additional contribution to the pathogenesis of pulmonary hypertension in cases with elevated left atrial pressure.
No takes yet. Share an insight, caveat, or question.
Yutaka Yoshida (1969) conducted an observational in Mitral valvular disease with elevated left atrial pressure. 100 per cent oxygen and sympathetic blocking agents (phentolamine and hexamethonium) vs. Control subjects was evaluated on Pulmonary arteriolar resistance and urinary catecholamine levels (r=0.62). Administration of sympathetic blocking agents and 100% oxygen reduced pulmonary arteriolar resistance in patients with mitral valvular disease, correlating with sympathetic hyperactivity (r=0.62).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: